ACC 2019: Duration of Diabetes and Cardiorenal Efficacy of Liraglutide and Semaglutide

Published: 11 Apr 2019

  • Views:

    Views Icon 128
  • Likes:

    Heart Icon 2
Average (ratings)
No ratings
Your rating

Prof Subodh Verma (University of Toronto, Toronto, CA) discusses his poster presented at the ACC 2019 titled duration of diabetes and cardiorenal efficacy of liraglutide and semaglutide - a post hoc analysis of the LEADER and SUSTAIN-6 Clinical Trials

Filmed on site at ACC 2019 by Radcliffe Cardiology


Videography: Josh Birch

Interviewer: Liam O'Neill

This video was supported by a grant from Novo Nordisk